Potential Spatial Mismatches Between Marine Predators and Their Prey in the Southern Hemisphere in Response to Climate Change.

Global change is rapidly reshaping species' habitat suitability ranges, hence leading to significant shifts in the distribution of marine life. Contrasting distributional responses among species can alter the spatial overlap between predators and prey, potentially disrupting trophic interactions and affecting food web dynamics. Here, we evaluate long-term changes in the spatial overlap of habitat suitability ranges for trophically related species, including crustaceans, fish, penguins, and pinnipeds across 12 Large Marine Ecosystems from the Southern Hemisphere, merged into three primary regions: South America, Southern Africa, Australia and New Zealand.

Factors Associated With Quality of Life Among Colorectal Cancer Patients: Cross-Sectional Study.

Introduction: Colorectal cancer is a chronic condition that affects a substantial proportion of the global population. Ensuring a satisfactory quality of life (QoL) for these patients is, therefore, of critical importance.

Objective: To examine the relationship between sociodemographic, economic, lifestyle, and health-related variables and quality of life in patients with colorectal cancer receiving treatment at a leading health institution in Medellín, Colombia.

Microbiome contributions to pain: a review of the preclinical literature.

Over the past 2 decades, the microbiome has received increasing attention for the role that it plays in health and disease. Historically, the gut microbiome was of particular interest to pain scientists studying nociplastic visceral pain conditions given the anatomical juxtaposition of these microorganisms and the neuroimmune networks that drive pain in such diseases. More recently, microbiomes both inside and across the surface of the body have been recognized for driving sensory symptoms in a broader set of diseases.

Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors.

Immune checkpoint inhibitors (ICIs) targeting the programmed cell death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) pathway have transformed urothelial cancer (UC) therapy. The correlation between PD-L1 expression and ICI effectiveness is uncertain, leaving the role of PD-L1 as a predictive marker for ICI efficacy unclear. Among several ways to enhance the efficacy of ICI, trials are exploring combining ICIs with serine/threonine-protein kinase mTOR (mTOR) inhibitors in different tumor types.